Ísrael - hebreska - Ministry of Health

medison pharma ltd - ponatinib as hydrochloride - טבליות מצופות - ponatinib as hydrochloride 15 mg - ponatinib

Ísrael - hebreska - Ministry of Health

medison pharma ltd - ponatinib as hydrochloride - טבליות מצופות - ponatinib as hydrochloride 15 mg - ponatinib

Ísrael - hebreska - Ministry of Health

medison pharma ltd - ponatinib as hydrochloride - טבליות מצופות - ponatinib as hydrochloride 30 mg - ponatinib

Ísrael - hebreska - Ministry of Health

medison pharma ltd - ponatinib as hydrochloride - טבליות מצופות - ponatinib as hydrochloride 30 mg - ponatinib

Ísrael - hebreska - Ministry of Health

medison pharma ltd - ponatinib as hydrochloride - טבליות מצופות - ponatinib as hydrochloride 45 mg - ponatinib

Ísrael - hebreska - Ministry of Health

medison pharma ltd - ponatinib as hydrochloride - טבליות מצופות - ponatinib as hydrochloride 45 mg - ponatinib

Ísrael - hebreska - Ministry of Health

baxter healthcare distribution ltd., israel - calcium chloride dihydrate; icodextrin; magnesium chloride hexahydrate; sodium (s) - lactate; sodium chloride - תמיסה לדיאליזה פריטוניאלית - icodextrin 75 g/l; magnesium chloride hexahydrate 0.051 g/l; calcium chloride dihydrate 0.257 g/l; sodium (s) - lactate 4.5 g/l; sodium chloride 5.4 g/l - dextran - dextran - once daily replacement of a single glucose exchange as part of continuous ambulatory peritoneal dialysis (capd) or automated peritoneal dialysis (apd) in the treatment of chronic renal failure.

Ísrael - hebreska - Ministry of Health

baxter healthcare distribution ltd., israel - calcium chloride dihydrate; glucose monohydrate (as anhydrous); lactic acid as sodium; magnesium chloride hexahydrate; sodium bicarbonate; sodium chloride - תמיסה לדיאליזה פריטוניאלית - sodium chloride 5.38 g/l; magnesium chloride hexahydrate 0.051 g/l; lactic acid as sodium 1.68 g/l; sodium bicarbonate 2.10 g/l; glucose monohydrate (as anhydrous) 13.6 g/l; calcium chloride dihydrate 0.184 g/l - sodium chloride - sodium chloride - physioneal is indicated whenever peritoneal dialysis is employed including:acute and chronic renal failure severe water retention severe electrolyte imbalance drug intoxication with dialysable substances when a more adequate therapeutic alternative is not available. bicarbonate/lactate based physioneal peritoneal dialysis solutions with a physiological ph are particularly indicated in patients in whom solutions based on lactate buffer only with a low ph cause abdominal inflow pain or discomfort.

Ísrael - hebreska - Ministry of Health

baxter healthcare distribution ltd., israel - calcium chloride dihydrate; glucose monohydrate (as anhydrous); lactic acid as sodium; magnesium chloride hexahydrate; sodium bicarbonate; sodium chloride - תמיסה לדיאליזה פריטוניאלית - sodium chloride 5.38 g/l; glucose monohydrate (as anhydrous) 22.7 g/l; calcium chloride dihydrate 0.184 g/l; lactic acid as sodium 1.68 g/l; magnesium chloride hexahydrate 0.051 g/l; sodium bicarbonate 2.10 g/l - sodium chloride - sodium chloride - physioneal is indicated whenever peritoneal dialysis is employed including:acute and chronic renal failure severe water retention severe electrolyte imbalance drug intoxication with dialysable substances when a more adequate therapeutic alternative is not available. bicarbonate/lactate based physioneal peritoneal dialysis solutions with a physiological ph are particularly indicated in patients in whom solutions based on lactate buffer only with a low ph cause abdominal inflow pain or discomfort.

Ísrael - hebreska - Ministry of Health

baxter healthcare distribution ltd., israel - calcium chloride dihydrate; glucose monohydrate (as anhydrous); lactic acid as sodium; magnesium chloride hexahydrate; sodium bicarbonate; sodium chloride - תמיסה לדיאליזה פריטוניאלית - sodium chloride 5.38 g/l; magnesium chloride hexahydrate 0.051 g/l; calcium chloride dihydrate 0.184 g/l; sodium bicarbonate 2.10 g/l; glucose monohydrate (as anhydrous) 38.6 g/l; lactic acid as sodium 1.68 g/l - calcium chloride - calcium chloride - physioneal is indicated whenever peritoneal dialysis is employed including:acute and chronic renal failure; severe water retention; severe electrolyte imbalance; drug intoxication with dialysable substances when a more adequate therapeutic alternative is not available. bicarbonate/lactate based physioneal peritoneal dialysis solutions with a physiological ph are particularly indicated in patients in whom solutions based on lactate buffer only with a low ph cause abdominal inflow pain or discomfort.